Importance of identifying the early emergence of metastatic disease in prostate cancer

In this Urology Times educational supplement, we review the importance of understanding the CRPC–mCRPC transition in order to optimize standard screening procedures and identify patients with early metastatic disease who may benefit from therapeutic intervention.

 

 

Related Videos
Colin P. West, MD, PhD, answers a question during a Zoom interview
Dr. Brian Rini in an interview
Bradley McGregor, MD, answers a question during a video interview
Dr. Sarah Psutka in an interview
Dr. Thomas Hutson in an interview at the ASCO annual meeting
© 2023 MJH Life Sciences

All rights reserved.